1.
Drug Discov Today
; 26(8): 1784-1789, 2021 08.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34022459
RESUMEN
Comparative analysis of the R&D efficiency of 14 leading pharmaceutical companies for the years 1999-2018 shows that there is a close positive correlation between R&D spending and the two investigated R&D output parameters, approved NMEs and the cumulative impact factor of their publications. In other words, higher R&D investments (input) were associated with higher R&D output. Second, our analyses indicate that there are 'economies of scale' (size) in pharmaceutical R&D.